A Study of AK0529 to Evaluate Pharmacokinetics and Safety in Chinese Healthy Volunteers
Clinical trial NCT03322800 · COMPLETED
Trial details
- NCT number
- NCT03322800
- Sponsor
- Shanghai Ark Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-23
- Primary completion
- 2018-04-06
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.